Click Here to Corporate video
Through Quality
healthcare solutions to ensure accessibility to more people.
Annual Communique 2023
Therapeutic solutions for well-being and life. We are focused, so our patients can live their life to the fullest.
MEDICAMEN Biotech Limited (MBL) is committed to providing quality medicines at an affordable cost through relentless pursuit of excellence in its operations, product quality, documentation and service.
Product Approvals in Emerging Markets
State-of-the-Art Manufacturing Facility(API, FDF)
Employees
Oncology Products in pipeline
Regulatory Agency Approvals
Total Products in pipeline for EU and Australia
OFFERINGS
Committed to providing solutions to the pharmaceutical industry across the value chain
Over the last decade, Medicamen has emerged as an integrated Pharmaceutical and Life Sciences Solution Provider offering products & services to its customers across the globe.
ANTI-MALARIAL
VITAMINS
ANTIBIOTICS
RESEARCH AND DEVELOPMENT
Fostering a culture of innovation through collaboration for developing enhanced solutions
We believe that our R&D has led, and will continue to lead to new, innovative processes that can increase the efficiencies of production including developing cost effective manufacturing processes, as well as address opportunities that we have identified in the global market for our businesses.
MEDICAMEN BIOTECH IN NEWS
Latest Medicamen News and Updates
BSE/NSE LISTING
Medicamen Ltd. Live BSE Share Price today.
INVESTOR INFORMATION
Medicamen Financial Information
CORPORATE PROFILE
Corporate Profile available for download.
NEWS UPDATE
Listing Of Equity Shares of Medicamen Biotech Limited on National Stock Exchange Of India Limited ('NSE')
